We are international
Donate
• treatment options TEXT SIZE   
novel therapies    back

Dr. Moreau - A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma
Philippe Moreau, MD
University Hospital
Nantes, France
12.02.10

Be the first to comment

 related articles